“…Commercial sources of the primary reagents and consumables used in this study were as follows: ferric chloride (FeCl 3 ·6H 2 O), ferrous chloride (FeCl 2 ·4H 2 O), 25% ammonium solution (25%), PCA, ammonium persulfate (APS), 2,7-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM), dexamethasone (Dexa), Dulbecco’s modified Eagle’s medium, ethylenediaminetetraacetic acid tetrasodium salt dihydrate (EDTA), glycerol, hydrochloric acid (HCl), lipopolysaccharides from Escherichia coli serotype O111:B, 2-mercaptoethanol, N , N , N ′, N ′-Tetramethyl ethylenediamine (TEMED), phenylmethylsulphonyl fluoride (PMSF), paraformaldehyde (PFA), Ponceau S solution, potassium hexacyanoferrate(II) trihydrate, RPMI-1640 medium, sodium dodecyl sulphate (SDS), Triton-X-100, and Tris-HCl, which were purchased from SIGMA-Aldrich (Merck KGaA, Darmstadt, Germany); fetal bovine serum and penicillin/streptomycin, which were purchased from Thermo Fisher Scientific (Waltham, MA, USA); recombinant human tumor necrosis factor-alpha (TNF-α) from R&D Systems, Inc. (Abingdon, UK); cell culture dishes, which were purchased from TPP ® (Trasadingen, Switzerland); the transparent/black 96-well micro test plates, F-bottom, which were purchased from Ratiolab (Ratiolab GmbH, Dreieich, Germany); and UV 96-well micro test plates, F-bottom, which were purchased from Corning Inc. (New York, NY, USA). Dextran was biosynthesized as exopolysaccharides from Weissella confusa , a yogurt-isolated lactic acid bacterium, as previously reported [ 20 ]. A culture medium consisting of DeMan-Rogosa-Sharpe (MRS) agar (55.3 g/L) and sucrose (80 g/L) dissolved in UHT milk was inoculated with Weissella confusa , and after 48 h of fermentation, the dextran was extracted and purified as detailed in [ 21 ].…”